S E Sallan Selected Research

Tensins

9/2014

Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S E Sallan Research Topics

Disease

9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018 - 04/2000
3	Neoplasms (Cancer) 08/2001 - 04/2000
2	Cardiotoxicity 01/2017 - 11/2016
1	Infections 01/2018
1	Mycoses (Diseases, Fungus) 01/2018
1	Bacteremia 01/2018
1	Fever (Fevers) 01/2018
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 09/2014
1	Leukemia 08/2001
1	Cognitive Dysfunction 07/2001
1	Osteonecrosis (Kienbock's Disease) 06/2001
1	Sepsis (Septicemia) 04/2000

Drug/Important Bio-Agent (IBA)

3	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2001 - 05/2000
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 11/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 05/2000 - 04/2000
2	Prednisone (Sone)FDA LinkGeneric 05/2000 - 04/2000
1	FluoroquinolonesIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	AnthracyclinesIBA 11/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2014
1	Peptides (Polypeptides)IBA 09/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2014
1	TensinsIBA 09/2014
1	VaccinesIBA 08/2001
1	CC ChemokinesIBA 08/2001
1	Neoplasm Antigens (Tumor Antigens)IBA 08/2001
1	Chemotactic FactorsIBA 08/2001

Therapy/Procedure

3	Therapeutics 07/2001 - 04/2000
1	Induction Chemotherapy 01/2018
1	Antibiotic Prophylaxis 01/2018
1	Immunotherapy 08/2001
1	Ligation 08/2001
1	Radiotherapy 07/2001
1	Remission Induction 04/2000